Literature DB >> 9371904

Mn SOD activity and protein in a patient with chromosome 6-linked autosomal recessive parkinsonism in comparison with Parkinson's disease and control.

S Shimoda-Matsubayashi1, T Hattori, H Matsumine, A Shinohara, A Yoritaka, H Mori, T Kondo, M Chiba, Y Mizuno.   

Abstract

We report Mn superoxide dismutase (SOD) protein and activity in a patient with familial autosomal recessive Lewy body-negative parkinsonism in comparison with patients with sporadic Parkinson's disease (PD) and controls. We recently proved linkage of this family with markers of chromosome 6 at 6q25.2-27, which included the Mn SOD gene. We used a novel polymorphic mutation at -9 position of the signal peptide of the Mn SOD precursor protein, which caused valine to alanine substitution. All the affected members of this family showed homozygosity for alanine, whereas nonaffected members, sporadic PD patients, and the control subjects studied showed either heterozygosity of alanine and valine or homozygosity of valine. The Mn SOD activity of this familial patient was the highest among the PD patients and the control subjects studied, and an abundant expression of Mn SOD was found in the substantia nigra. The molecular weight of Mn SOD protein by Western blotting of this patient was essentially similar to that of PD patients and the control subjects. High Mn SOD activity may constitute a genetic risk factor in this familial patient. The difference in the signal peptide sequence may affect the expression of Mn SOD within mitochondria; however, it is unlikely that loss of function type Mn SOD mutation is the cause of this familial parkinsonism. Mn SOD in sporadic PD patients was similar to that in controls.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9371904     DOI: 10.1212/wnl.49.5.1257

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  15 in total

1.  Individual Amino Acid Supplementation Can Improve Energy Metabolism and Decrease ROS Production in Neuronal Cells Overexpressing Alpha-Synuclein.

Authors:  Vedad Delic; Jeddidiah W D Griffin; Sandra Zivkovic; Yumeng Zhang; Tam-Anh Phan; Henry Gong; Dale Chaput; Christian Reynes; Vinh B Dinh; Josean Cruz; Eni Cvitkovic; Devon Placides; Ernide Frederic; Hamed Mirzaei; Stanley M Stevens; Umesh Jinwal; Daniel C Lee; Patrick C Bradshaw
Journal:  Neuromolecular Med       Date:  2017-06-15       Impact factor: 3.843

Review 2.  Twenty years since the discovery of the parkin gene.

Authors:  Nobutaka Hattori; Yoshikuni Mizuno
Journal:  J Neural Transm (Vienna)       Date:  2017-06-15       Impact factor: 3.575

3.  Cognitive function, plasma MnSOD activity, and MnSOD Ala-9Val polymorphism in patients with schizophrenia and normal controls.

Authors:  Xiang Y Zhang; Da C Chen; Mei H Xiu; Fu D Yang; Yunlong Tan; Xingguang Luo; Lingjun Zuo; Therese A Kosten; Thomas R Kosten
Journal:  Schizophr Bull       Date:  2013-04-15       Impact factor: 9.306

4.  Participation of 47C>T SNP (Ala-9Val polymorphism) of the SOD2 gene in the intracellular environment of human peripheral blood mononuclear cells with and without lipopolysaccharides.

Authors:  Francis Jackson O Paludo; André Simões-Pires; Clarice S Alho; Daniel Pens Gelain; José Cláudio F Moreira
Journal:  Mol Cell Biochem       Date:  2012-09-15       Impact factor: 3.396

5.  Interrelationships Between BDNF, Superoxide Dismutase, and Cognitive Impairment in Drug-Naive First-Episode Patients With Schizophrenia.

Authors:  Mei Hong Xiu; Zezhi Li; Da Chun Chen; Song Chen; Maile E Curbo; Hanjing Emily Wu; Yong Sheng Tong; Shu Ping Tan; Xiang Yang Zhang
Journal:  Schizophr Bull       Date:  2020-12-01       Impact factor: 9.306

6.  Association of SOD2, a mitochondrial antioxidant enzyme, with gray matter volume shrinkage in alcoholics.

Authors:  Vibhuti Srivastava; Beata Buzas; Reza Momenan; Gabor Oroszi; Attila J Pulay; Mary-Anne Enoch; Daniel W Hommer; David Goldman
Journal:  Neuropsychopharmacology       Date:  2009-12-30       Impact factor: 7.853

7.  Polymorphisms in the Mn-SOD and EC-SOD genes and their relationship to diabetic neuropathy in type 1 diabetes mellitus.

Authors:  D A Chistyakov; K V Savost'anov; E V Zotova; V V Nosikov
Journal:  BMC Med Genet       Date:  2001-03-28       Impact factor: 2.103

8.  Gene polymorphisms of superoxide dismutases and catalase in diabetes mellitus.

Authors:  Milan Flekac; Jan Skrha; Jirina Hilgertova; Zdena Lacinova; Marcela Jarolimkova
Journal:  BMC Med Genet       Date:  2008-04-21       Impact factor: 2.103

9.  Meta-Analyses of Manganese Superoxide Dismutase Activity, Gene Ala-9Val Polymorphism, and the Risk of Schizophrenia.

Authors:  Dong-Fang Wang; Bing Cao; Mei-Yan Xu; Ya-Qiong Liu; Lai-Lai Yan; Rong Liu; Jing-Yu Wang; Qing-Bin Lu
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

10.  Evaluation of genetic polymorphisms in patients with multiple chemical sensitivity.

Authors:  Xiaoyi Cui; Xi Lu; Mizue Hiura; Masako Oda; Wataru Miyazaki; Takahiko Katoh
Journal:  PLoS One       Date:  2013-08-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.